Home ::> Staff Listings ::> Staff Listing by Name ::> B ::> Hannah Briemberg
STAFF LISTING
Dr. Hannah R. Briemberg
Clinical Assistant Professor
Addresses:
Neuromuscular Diseases Unit
8th floor, Diamond Centre
2775 Laurel Street
Vancouver BC Canada V5Z 1M9Tel: (604) 875-4247
Fax: (604) 875-4405
Email: Hannah.briemberg@vch.ca
Research Interests:
Muscle disease, ALS
Professional Training:
2000 - 2002: Fellowship training in EMG and neuromuscular disease, Brigham and Women’s Hospital, Harvard University
1996 - 1999: Neurology residency, Harvard University (Longwood Program)
1995: Internship, Sunnybrook Hospital, University of Toronto
1991 - 1994: Medical school, McMaster University
1983 - 1988: Bachelor of Science in Occupational Therapy, University of British Columbia
Academic Positions:
2008 - present: Medical Director, ALS Clinic (GF Strong Rehabilitation Hospital)
2004 - present: Clinical Assistant Professor, Division of Neurology (University of British Columbia)
2002 - 2004: Instructor in Neurology (Harvard Medical School)
Honours and Awards:
Marcel Bertrand Exceptional Support Services Program Award 2009 (awarded from ALS Canada in recognition of the exceptional support provided by the ALS Clinic at GF Strong to the ALS patients it serves)
Board Representation:
Medical and scientific advisory committee of Muscular Dystrophy Canada (July 2007-present)
Publications
Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan E, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg HR, Schlossman RL, Munchi NC, Thompson Heffner L, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy and molecular correlations with response and neuropathy. J Clin Oncol 2009 Jun 15, [Epub ahead of print] [PubMed]
Briemberg HR. Peripheral nerve complications of medical disease. Seminars in Neurology 2009:29(2);124-135.[PubMed]
The Muscle Study Group. A Trial of Mycophenolate Mofetil with Prednisone as Initial Immunotherapy in Myasthenia Gravis. Neurology 2008:71(6);394-399. [PubMed]
Alotaibi N, Briemberg H. Evaluation of upper extremity mononeuropathy. BMJ Point-of-Care 2008; www.pointofcare.bmj.com
Lee MS, Kosmorsky GS, Cook JR, Barton JJS, Briemberg HR. My, What Asthenia You Have. Survey of Ophthalmology 2008:53(5);506-511. [PubMed]
Briemberg HR, Amato AA. Approach to Sensory Loss. In: UpToDate, Rose BD (ed), UpToDate, Wellesley, MA, 2007.
Briemberg HR. Neuromuscular Diseases in Pregnancy. Seminars in Neurology 2007:27(5)460-466. [PubMed]
*Richardson PG, *Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, Singhal S, Siegel DS, Kayd E, Irwin D, Schuster M, Srkalovic G, Alexanian R, Rajkumar SV, Limentani S, Alsina M, Orlowski RZ, Najarian K, Esseltine D, Collins D, Anderson KC, Amato, AA. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. Journal of Clinical Oncology; 2006;24(19):3113-20.
*Dr, Briemberg and Dr. Richardson are co-first authors. [PubMed]Briemberg HR. 10 Most Commonly Asked Questions About Idiopathic Inflammatory Myopathies. Neurologist; 2005 Jul;11(4):250-3. [PubMed]
Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA. Interferon-α/β Mediated Innate Immune Mechanisms in Dermatomyositis. Annals of Neurology; 2005;57:664-678. [PubMed]
Briemberg HR, Amato AA. Inflammatory Neuropathies. Current Neurology and Neuroscience Reports 2005;5(1):66-71. [PubMed]
Muscle Study Group. Randomized pilot trial of high-dose beta INF 1a in patients with inclusion body myositis. Neurology 2004;63(4):718-20. [PubMed]
Greenberg SA, Briemberg HR. A neurological and hematological syndrome associated with zinc excess and copper deficiency. J Neurol 2004;251:111-114. [PubMed]
Briemberg HR, Amato AA. Transthyretin amyloidosis presenting with multifocal mononeuropathies. Muscle Nerve. 2004;29(2):318-22. [PubMed]
Briemberg HR, Amato AA. “Inflammatory Myopathies. In: Clinical neurophysiology of disorders of muscle and neuromuscular junction, including fatigue. Handbook of Clinical Neurophysiology, Vol. 2. J.R. Daube and F. Mauguiere (Ser. Eds.), Erik Stalberg (Vol. Ed.), Elsevier, 2003, pp. 415-429.
Briemberg HR, Amato AA. Dermatomyositis and Polymyositis. Current Treatment Options in Neurology 2003;5:349-356. [PubMed]
Briemberg HR, Amato AA. Neuromuscular Complications of Cancer. Neurol Clin N Am 2003;21:141-165. [PubMed]
Briemberg H, Amato A., “Muscular Dystrophy: Emery-Dreifuss, Facioscapulohumeral, Scapuloperoneal, and Bethlem Myopathy” In: Encyclopedia of the Neurological Sciences (M. Aminoff, R. Daroff, eds), Vol. 3, pp. 288-292, Academic Press, San Diego 2003.
Briemberg HR, Levin K, Amato AA. Multifocal conduction block in peripheral nerve vasculitis, J Clin Neuromusc Dis 2002; 3(4):153-158. [PubMed]
